论文部分内容阅读
目的 :探讨尼莫通 (0 .0 2 %尼莫地平溶液 )治疗外伤性蛛网膜下腔出血的作用 ,以及最佳用药时间。方法 :甲组不用尼莫通 ;乙组 2 4h内用尼莫通 ;丙组 72h后用尼莫通。观察疗效 ,并进行疗效分析。结果 :早期应用尼莫通比晚期应用以及不用尼莫通对部分脑功能疗效差异有显著性 (P <0 .0 5 ) ;CT扫描显示早期应用尼莫通者与不用者脑水肿坏死病灶比较差异有显著性 (P <0 .0 1) ;72h后用尼莫通者与不用尼莫通者比较差异无显著性 (P >0 .0 5 )。结论 :尼莫通对外伤性蛛网膜下腔出血脑功能恢复有明显的疗效 ,而且用药愈早疗效愈显著。CT扫描不能作为脑功能恢复的主要指标。
Objective: To investigate the effect of nimotong (0.2% nimodipine solution) on traumatic subarachnoid hemorrhage and the best medication time. Methods: Nimotone was not used in group A; nimotong was used in group B within 24 hours; nimodipine was used in group C after 72 hours. Observation of efficacy, and efficacy analysis. Results: The early application of nimotopin late application and no effect of nimotop on some brain function difference was significant (P <0. 05); CT scan showed early use of nimotone and non-users of brain edema and necrosis lesions compared There was no significant difference between the two groups (P <0.01). There was no significant difference between the two groups (P> 0.05) after 72 hours. Conclusion: Nimotop has a significant effect on recovery of brain function after traumatic subarachnoid hemorrhage, and the more effective the treatment is, the more effective it is. CT scan can not be as a major indicator of brain function recovery.